Viewing StudyNCT04878055



Ignite Creation Date: 2024-05-06 @ 4:07 PM
Last Modification Date: 2024-10-26 @ 2:04 PM
Study NCT ID: NCT04878055
Status: COMPLETED
Last Update Posted: 2024-06-13
First Post: 2021-04-30

Brief Title: Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia
Sponsor: Dompé Farmaceutici SpA
Organization: Dompé Farmaceutici SpA

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-02-14
Start Date Type: ACTUAL
Primary Completion Date: 2021-09-30
Primary Completion Date Type: ACTUAL
Completion Date: 2021-10-31
Completion Date Type: ACTUAL
First Submit Date: 2021-04-30
First Submit QC Date: May 6 2021
Study First Post Date: 2021-05-07
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2024-06-13
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-05-20
Last Update Post Date: 2024-06-13
Last Update Post Date Type: ACTUAL